About
Skintelligence is the developer of clinical decision support systems (CDSSs) designed to predict an individuals response to biological therapy, specifically in the treatment of autoimmune diseases such as psoriasis, rheumatoid arthritis, and Crohns disease. The companys solution enables physicians to prescribe biological medication while avoiding the typical process of trial and error, thereby reducing both the high cost of biological treatments and the patients discomfort. Skintelligences CDSSs are based on artificial intelligence tools that enable the compilation of information fundamental to predicting a patients response to therapy. The companys patented SmartPAD (SMART Predictor for Autoimmune Diseases) comprises a device that measures immunologic biomarkers from the skin using non-invasive assays and software that integrates the biomarkers from the skin with clinical data to calculate the probability of treatment success with each of the commercial biological drugs.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Skintelligence's primary focus?
- Skintelligence develops clinical decision support systems (CDSSs) to predict individual responses to biological therapy, particularly for autoimmune diseases like psoriasis, rheumatoid arthritis, and Crohn's disease.
- What is the status of Skintelligence?
- Skintelligence is currently inactive, having ceased operations in December 2021.
- When was Skintelligence founded?
- Skintelligence was founded in April 2018.
- Where is Skintelligence headquartered?
- Skintelligence is headquartered in Jerusalem, Israel.
- What is Skintelligence's patented product?
- Skintelligence's patented product is SmartPAD (SMART Predictor for Autoimmune Diseases), which uses a device for non-invasive skin biomarker measurement and software to predict treatment success.
- What technologies does Skintelligence utilize in its CDSSs?
- Skintelligence's CDSSs are based on artificial intelligence and machine learning tools.
- Has Skintelligence received any grants?
- Yes, Skintelligence received a grant from the IIA in December 2018.
- How many employees did Skintelligence have?
- Skintelligence had 5 employees.
- What is Skintelligence's current funding stage?
- Skintelligence's current funding stage is Pre-Funding.